75 results
8-K
EX-10.1
RENB
Renovaro Inc.
13 Mar 24
Departure of Directors or Certain Officers
9:30am
10-Q
2024 Q1
EX-10.3
RENB
Renovaro Inc.
Quarterly report
14 Nov 23
5:00pm
10-K/A
2023 FY
EX-10.12
RENB
Renovaro Inc.
Annual report (amended)
30 Oct 23
9:15am
8-K
EX-10.1
RENB
Renovaro Inc.
10 Oct 23
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-10.1
RENB
Renovaro Inc.
7 Aug 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.2
2km9v00qfgdz4me6ou2
7 Aug 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.1
joxdqyjvtciqkm
28 Jun 23
Entry into a Material Definitive Agreement
7:44am
8-K
EX-10.1
101ukwr6u0hc1
26 Jun 23
Entry into a Material Definitive Agreement
5:56pm
8-K
EX-10.2
1g6y 62q23
26 Jun 23
Entry into a Material Definitive Agreement
5:56pm
8-K
EX-10.1
5eul9fii
3 Apr 23
Entry into a Material Definitive Agreement
9:20am
8-K
EX-10.2
cikc3j c2tqiityco
23 Feb 23
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
9ed5v
23 Feb 23
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.3
0b7l91wm1ol84w98my
23 Feb 23
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
kjsqymfq
16 Dec 22
Departure of Directors or Certain Officers
4:27pm
8-K/A
EX-10.1
9koksd9m2sg
16 Aug 21
Entry into a Material Definitive Agreement
4:44pm
8-K
EX-10
1pa0cwt w424vlx2
16 Jun 21
Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:09pm
8-K
EX-10
iq8wkgdraw22
16 Jun 21
Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:09pm
8-K
EX-10.1
595mv2uzgyi9x2
22 Apr 21
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-10.1
idux38
24 Mar 21
Publish a Case Report of Complete Remission of
5:00pm
8-K
EX-10.1
gtu0ruwc2 bd
14 Jul 20
Entry into a Material Definitive Agreement
8:59am